Evidence map›Paper›PMID 33395415›Full record

ArticlePloS one2021

Modeling adaptive reversible lanes: A cellular automata approach.

Dante Pérez-Méndez, Carlos Gershenson, María Elena Lárraga, José L Mateos

Abstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Dante Pérez-MéndezInstituto de Investigaciones en Matemáticas Aplicadas y en Sistemas, Universidad Nacional Autónoma de México, Ciudad de México, México.ORCID 0000-0002-9213-0501
Carlos GershensonInstituto de Investigaciones en Matemáticas Aplicadas y en Sistemas, Universidad Nacional Autónoma de México, Ciudad de México, México.ORCID 0000-0003-0193-3067
María Elena LárragaInstituto de Ingeniería, Universidad Nacional Autónoma de México, Ciudad de México, México.
José L MateosCentro de Ciencias de la Complejidad, Universidad Nacional Autónoma de México, Ciudad de México, México.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dealing with traffic congestion is one of the most pressing challenges for cities. Transport authorities have implemented several strategies to reduce traffic jams with varying degrees of success. The use of reversible lanes is a common approach to improve traffic congestion during rush hours. A reversible lane can change its direction during a time interval to the more congested direction. This strategy can improve traffic congestion in specific scenarios. Most reversible lanes in urban roads are fixed in time and number; however, traffic patterns in cities are highly variable and unpredictable due to this phenomenon's complex nature. Therefore, reversible lanes may not improve traffic flow under certain circumstances; moreover, they could worsen it because of traffic fluctuations. In this paper, we use cellular automata to model adaptive reversible lanes(aka dynamic reversible lanes). Adaptive reversible lanes can change their direction using real-time information to respond to traffic demand fluctuations. Using real traffic data, our model shows that adaptive reversible lanes can improve traffic flow up to 40% compared to conventional reversible lanes. Our results show that there are significant fluctuations in traffic flow even during rush hours, and thus cities would benefit from implementing adaptive reversible lanes.

Indexed as

Models, TheoreticalAutomobile DrivingCitiesComputer SimulationEnvironment Design

Identifiers

PMID33395415
PMCPMC7781372

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.